120 related articles for article (PubMed ID: 12113129)
1. Aronex Pharmaceuticals reports on annamycin phase I trial.
Expert Rev Anticancer Ther; 2001 Jun; 1(1):4. PubMed ID: 12113129
[No Abstract] [Full Text] [Related]
2. Doxorubicin-induced myocardial injury.
Fujisaki G; Inokuchi C; Murashige N
N Engl J Med; 2004 Oct; 351(18):1908-9; author reply 1908-9. PubMed ID: 15509827
[No Abstract] [Full Text] [Related]
3. Sudden death of a patient in complete remission after anthracycline therapy for acute lymphoblastic leukemia.
Tsuda N; Oka R; Kajino H; Kajino M; Okuno A
Pediatr Int; 2000 Jun; 42(3):319-21. PubMed ID: 10881596
[No Abstract] [Full Text] [Related]
4. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
[TBL] [Abstract][Full Text] [Related]
5. Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia?
Silber JH
Nat Clin Pract Oncol; 2004 Nov; 1(1):16-7. PubMed ID: 16264791
[No Abstract] [Full Text] [Related]
6. [Development of myocardiopathy during treatment of acute lymphoblastic leukemia with anthracycline antibiotics].
Radojković B; Elezović I; Vujisić-Tesić B
Srp Arh Celok Lek; 1988 Apr; 116(4):347-54. PubMed ID: 3187761
[No Abstract] [Full Text] [Related]
7. Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia.
Wetzler M; Thomas DA; Wang ES; Shepard R; Ford LA; Heffner TL; Parekh S; Andreeff M; O'Brien S; Kantarjian HM
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):430-4. PubMed ID: 23763920
[TBL] [Abstract][Full Text] [Related]
8. Drug may protect children's hearts from chemotherapy.
McBride D
ONS Connect; 2010 Dec; 25(12):15. PubMed ID: 21214085
[No Abstract] [Full Text] [Related]
9. [Dexrazoxane and cardiotoxicity in repeatedly treated patients].
Trnĕný M
Vnitr Lek; 2004 Jun; 50(6):417-8. PubMed ID: 15346632
[No Abstract] [Full Text] [Related]
10. Neurological improvement and rehabilitation potential following toxic myelopathy due to intrathecal injection of doxorubicin.
Jordan B; Pasquier Y; Schnider A
Spinal Cord; 2004 Jun; 42(6):371-3. PubMed ID: 14968106
[TBL] [Abstract][Full Text] [Related]
11. Pediatric leukemia in the new millennium.
Kaspers GJ
Expert Rev Anticancer Ther; 2001 Jun; 1(1):1-2. PubMed ID: 12113116
[No Abstract] [Full Text] [Related]
12. [Thioguanine, pancreatotoxicity?].
Bisschop D; Germain ML; Munzer M; Trenque T
Therapie; 2001; 56(1):67-9. PubMed ID: 11322024
[No Abstract] [Full Text] [Related]
13. [Experience of use of bruneomycin in leukemia].
Krasovskiĭ II; Kudinov VG
Antibiotiki; 1969 Jan; 14(1):77-81. PubMed ID: 5253409
[No Abstract] [Full Text] [Related]
14. [Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lü JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):750-2. PubMed ID: 16483490
[TBL] [Abstract][Full Text] [Related]
15. [Dilated cardiomyopathy post-chemotherapy].
Sbrana F; Greco P; Rovai D
Recenti Prog Med; 2009 Mar; 100(3):132-6. PubMed ID: 19475840
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline analogs: re-assessments and prospects.
Carter SK
Cancer Treat Rep; 1979 May; 63(5):935-6. PubMed ID: 455336
[No Abstract] [Full Text] [Related]
17. [Endocrine reproductive system in male patients with leukoses].
Rakoval AL; Ermolin AE; Belousov EA; Izgorodin AS
Voen Med Zh; 2001 Jun; 322(6):37-42. PubMed ID: 11550533
[No Abstract] [Full Text] [Related]
18. Reimmunization after therapy for childhood cancer.
Chisholm JC
Clin Infect Dis; 2007 Mar; 44(5):643-5. PubMed ID: 17278053
[No Abstract] [Full Text] [Related]
19. Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
Cragg LH; Andreeff M; Feldman E; Roberts J; Murgo A; Winning M; Tombes MB; Roboz G; Kramer L; Grant S
Clin Cancer Res; 2002 Jul; 8(7):2123-33. PubMed ID: 12114412
[TBL] [Abstract][Full Text] [Related]
20. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Büyükçelik A; Yalçin B; Utkan G; Doruk H
Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
